Print

Elite Pharmaceuticals, Inc. (ELI) ECR Pharmaceuticals Launch Lodrane D(R) Allergy Product  
9/27/2011 10:19:11 AM

NORTHVALE, N.J., Sept. 27, 2011 (GLOBE NEWSWIRE) -- Elite Pharmaceutical, Inc.'s ("Elite" or the "Company") (OTCBB:ELTP) and ECR Pharmaceuticals ("ECR"), a wholly owned subsidiary of Hi-Tech Pharmacal (Hi-Tech), announced today the launch of Lodrane D®. Lodrane D® is an immediate release formulation of brompheniramine maleate and pseudoephedrine HCl, an effective, low-sedating antihistamine combined with a decongestant.
//-->